Skip to main content
. 2015 Mar 1;26(5):901–912. doi: 10.1091/mbc.E14-07-1250

FIGURE 4:

FIGURE 4:

Effects of the nonmuscle myosin II inhibitor blebbistatin on APRC3+/+ and ARPC3−/− fibroblast cells. (A and B) Montage of phase-contrast movies showing the morphology of representative ARPC3+/+ (A) and ARPC3−/− (B) fibroblast cells spreading in the presence of blebbistatin (top row) and recovery after drug washout (bottom row). (C and D) Montage of phase-contrast movies showing already spread ARPC3+/+ (C) and ARPC3−/− (D) fibroblast cells treated with blebbistatin (top row) and recovery after drug washout (bottom row). Scale bars: 25 μm.